News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

INNOPHARMA Announces Launch of Generic Cidofovir Injection in the United States



3/8/2013 10:13:08 AM

PISCATAWAY, NJ, March 8, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the launch of cidofovir injection (generic equivalent of VistideĀ®) in 5mL single-use vials. InnoPharma developed the generic formulation of cidofovir, which will be marketed in the United States by Mylan, Inc. (NASDAQ: MYL). Cidofovir injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). For more information regarding this product, including its black box warning, please refer to the Mylan website at www.mylan.com.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES